CYP2A6 and lung carcinoma: CYP2A enzymes metabolize a variety of carcinogens including 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), which can lead to the development of lung cancer (Koskela et al. 1999).